Oral physostigmine in Alzheimer's disease: effects on norepinephrine and vasopressin in cerebrospinal fluid and plasma. (Q53319848)
Jump to navigation
Jump to search
scientific article published in October 1995
Language | Label | Description | Also known as |
---|---|---|---|
English | Oral physostigmine in Alzheimer's disease: effects on norepinephrine and vasopressin in cerebrospinal fluid and plasma. |
scientific article published in October 1995 |
Statements
Oral physostigmine in Alzheimer's disease: effects on norepinephrine and vasopressin in cerebrospinal fluid and plasma. (English)
Peskind ER
Raskind MA
Wingerson D
Pascualy M
Thal L
Veith RC
Dorsa DM
Bodenheimer S
1 October 1995
38
8
532-538